Pulling SEC filings + quote and writing the call…

ECB Bancorp, Inc. /MD/
Next earnings Jul 20, 2026
Last earnings -0.2% on 2026-04-23
Small, overcapitalized thrift trading near book with doubling earnings but sub-5% ROE — own it, don't chase it.
Diluted EPS $0.94 · FY2025
Middling fundamentals offset by an attractive price (~77% below fair value) — worth a look on the value angle.
First, a data-quality caveat that reframes everything: the tagged 'Revenue' of $598K (and the resulting 296x P/S and 1,300% net margin) is a mis-scoped XBRL contract-revenue line, not ECBK's real top line. As a savings institution its actual revenue is net interest income — the income statement shows interest and fees on loans of $69.1M and securities interest of $4.0M for FY2025. Ignore the P/S and margin ratios entirely; they are artifacts. The figures that matter are net income $7.77M (+94.7%), diluted EPS $0.94 (+95.8%), and equity of $171.9M against $1.61B assets.
The real story is a recently-converted thrift that is overcapitalized and just posted a sharp earnings recovery. Equity is ~10.7% of assets — very high for a bank — which is why ROE is only 4.5% despite earnings nearly doubling; the balance sheet is stuffed with IPO/ESOP capital that hasn't been put to work. That excess capital is a double-edged sword: it caps returns but funds the aggressive buyback ($4.61M paid, share count down 3.1% to 8.79M) and provides a thick loss-absorption cushion. Loans grew from $1.136B to $1.372B (+20.7%) with the allowance at ~0.75% of loans, and deposits rose to $1.13B — the engine is expanding, and the doubling of net income suggests margin/provisioning normalization is finally flowing through.
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | — | — | — | $577K | $598K |
| Gross profit | — | — | — | — | — |
| Operating income | — | — | — | — | — |
| Net income | $4.04M | $2.72M | $4.46M | $3.99M | $7.77M |
| Diluted EPS | — | $0.32 | $0.52 | $0.48 | $0.94 |
| Net margin | — | — | — | 691.7% | 1299.7% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Annual meeting vote results filed; routine director/auditor ratifications
Q1 2026 10-Q; loans/assets growth continues off record 2025 base
Q1 2026 earnings release; extends strong post-2025 profitability trend
2026 proxy for annual meeting; routine governance/compensation items
FY2025: net income +95% to $7.77M, loans up to $1.37B, clean audit opinion
Q4/FY2025 earnings: net income nearly doubled to $7.77M, EPS $0.94
Other-event disclosure (8.01) with exhibit; no material financial change signaled
Officer/director change disclosed under Item 5.02
Q3 2025 10-Q shows margin/earnings recovery driving full-year jump
Sources: SEC EDGAR (CIK 0001914605, latest 10-Q filed 2026-05-08) · EODHD · Proprietary analysis · as of 7/3/2026, 3:41:09 PM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
Last 90 days: 4 open-market buys · 0 sales
| 2026-04-30 | Lavertu Brandon CFO | Buy | 10.00 @ $17.85 | $178.50 |
| 2026-04-30 | Lavertu Brandon CFO | Buy | 10.00 @ $17.88 | $178.80 |
| 2026-04-30 | Lavertu Brandon CFO | Buy | 10.00 @ $17.91 | $179.10 |
| 2026-04-30 | Lavertu Brandon CFO | Buy | 10.00 @ $17.92 | $179.20 |
| 2026-02-09 | Sullivan Maura Ellen Director | Buy | 2.20K @ $18.50 | $40.7K |
| 2025-12-17 | Sullivan Maura Ellen Director | Award | 1.15K | |
| 2025-12-09 | Sullivan Maura Ellen Director | Buy | 400.00 @ $16.95 | $6.78K |
| 2025-12-09 | Sullivan Maura Ellen Director | Buy | 100.00 @ $17.04 | $1.70K |
| 2025-12-09 | Sullivan Maura Ellen Director | Buy | 63.00 @ $17.05 | $1.07K |
| 2025-12-08 | Sullivan Maura Ellen Director | Buy | 361.00 @ $16.65 | $6.01K |
| 2025-12-08 | Sullivan Maura Ellen Director | Buy | 200.00 @ $16.78 | $3.36K |
| 2025-12-08 | Sullivan Maura Ellen Director | Buy | 76.00 @ $16.80 | $1.28K |
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
1196 tracked peers · median